--- title: CAR-T Summit Tech Slam - TD2 Precision Oncology description: Driving preclinical success when developing CAR-T therapy programs image: https://td2inc.com/hubfs/Assets/Images/lp-td2-immuno-oncology-video-thumb-1.png --- ×   [![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en) ![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png) [![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en) ![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png) # Driving preclinical success when developing CAR-T therapy programs There are 3 main areas to take into consideration when developing your next preclinical program for [CAR-T therapy](https://td2inc.com/lp-car-t-study/?hsLang=en). Lean how the selected tumor model, cell viability, and study duration play an important role in driving your preclinical success. ![Video Thumbnail – TD2’s Immuno-Oncology Capabilities](https://td2inc.com/hubfs/Assets/Images/lp-td2-immuno-oncology-video-thumb-1.png) Watch Now ## CONTACT US ## Get Started. Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started. [Get Started Now](https://td2inc.com/contact-us/?hsLang=en) × [![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/td2-logo.png?width=160&name=td2-logo.png)](https://td2inc.com/?hsLang=en) Office 13208 E. Shea Blvd, Suite 100 Scottsdale, AZ 85259 Phone (602) 358-8300 Connect with us - - ![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/Assets/Logo/acclac-logo.png?width=139&name=acclac-logo.png) © 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)